IP Library Patent Application 19271641
Patent Application
App. No. 19/271,641

HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/271,641
Abstract

The present disclosure provides improved compositions for the homology directed repair of the human globin locus for the prevention, treatment, or amelioration of at least one symptom of a hemoglobinopathy.

Claims (25)

1 - 66 . (canceled)

67 . A DNA donor repair template comprising a sequence with at least 90% sequence identity to the sequence of any one of SEQ ID NOs: 17, 18, 19, 20, or 21.

68 . The DNA donor repair template of claim 67 , wherein the DNA donor repair template comprises a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 17.

69 . The DNA donor repair template of claim 67 , wherein the DNA donor repair template comprises a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 18.

70 . The DNA donor repair template of claim 67 , wherein the DNA donor repair template comprises a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 19.

71 . The DNA donor repair template of claim 67 , wherein the DNA donor repair template comprises a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 20.

72 . The DNA donor repair template of claim 67 , wherein the DNA donor repair template comprises a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 21.

73 . A viral vector comprising the DNA donor repair template of claim 67 .

74 . The viral vector of claim 73 , wherein the viral vector is a recombinant adeno-associated viral vector (rAAV) or a retrovirus.

75 . The viral vector of claim 74 , wherein the rAAV has one or more ITRs from AAV2.

76 . The viral vector of claim 74 , wherein the rAAV has a serotype selected from the group consisting of: AAV1, AAV2, AAV3, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, and AAV10.

77 . The viral vector of claim 74 , wherein the rAAV has an AAV6 serotype.

78 . The viral vector of claim 74 , wherein the retrovirus is a lentivirus.

79 . The viral vector of claim 78 , wherein the lentivirus is an integrase deficient lentivirus.

80 . A method for increasing gamma globin expression in a hematopoietic stem or progenitor cell comprising introducing into the cell:

one or more engineered nucleases that cleave a target site set forth in SEQ ID NO: 9; and

a DNA donor repair template having at least 90% sequence identity to the sequence of any one of SEQ ID NOs: 17, 18, 19, 20, or 21;

wherein the DNA donor repair template is inserted into the cell genome by homology directed repair at a double strand break introduced by the one or more engineered nucleases; and

wherein the inserted DNA donor repair template increases gamma globin expression in the hematopoietic stem or progenitor cell.

81 . The method of claim 80 , wherein the DNA donor repair template has a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 17.

82 . The method of claim 80 , wherein the DNA donor repair template has a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 18.

83 . The method of claim 80 , wherein the DNA donor repair template has a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 19.

84 . The method of claim 80 , wherein the DNA donor repair template has a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 20.

85 . The method of claim 80 , wherein the DNA donor repair template has a sequence having at least 90% sequence identity to the sequence of SEQ ID NO: 21.

86 . The method of claim 80 , wherein the DNA donor repair template has a sequence having at least 95% sequence identity to the sequence of any one of SEQ ID NOS: 17, 18, 19, 20, or 21.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2025
From: KIEM, HANS-PETER; HUMBERT, OLIVIER M.
To: FRED HUTCHINSON CANCER RESEARCH CENTER
Reel/Frame 072650/0486 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2025
From: SCHARENBERG, ANDREW; JACOBY, KYLE; RAWLINGS, DAVID J.; LUX, CHRISTOPHER; PATTABHI, SOWMYA
To: SEATTLE CHILDREN'S HOSPITAL (DBA SEATTLE CHILDREN'S RESEARCH INSTITUTE)
Reel/Frame 072650/0601 →
MERGER AND CHANGE OF NAME Recorded Oct 23, 2025
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 072650/0680 →